Meta-analysisindependent cross-checkabstract checked I-DRY-117 standard review

Yogurt and fermented milk do not raise inflammation

Effects of fermented dairy products on inflammatory biomarkers: A meta-analysis.

Overview

Zhang X et al.. Nutr Metab Cardiovasc Dis 2023 · PMID 36710113 · DOI 10.1016/j.numecd.2022.12.014

CRP slightly lower (SMD -0.21) across 14 trials.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Test fermented dairy and inflammation.

How was the study done?

Meta-analysis of trials.

How many people, animals or samples were studied?

14 trials.

What was actually found?

CRP slightly down; most markers unchanged.

How large was the observed effect?

CRP SMD -0.21.

What do the results mean in everyday life?

Yogurt does not inflame.

What are the study's limitations?

Few small trials.

What does it say about Elawady's specific claim?

Contradicts the claim.

Do the results apply to Germany and Europe?

Applicable.

What can explicitly not be concluded from this study?

Cannot show disease outcomes.

Scientific in-depth review

1. Full reference

Authors
Zhang X et al.
Journal
Nutr Metab Cardiovasc Dis
Year
2023
Identifier
PMID 36710113 DOI 10.1016/j.numecd.2022.12.014
Verification
verified – PubMed efetch 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

No conflicts declared.

2. Research question

Do fermented dairy products change inflammatory biomarkers?

3. Study design and population

Study design
Meta-analysis – Meta-analysis of controlled trials (PubMed, Web of Science, Embase, Cochrane)
Population

Adults in trials

Country

Multinational

Period

to 2022

Sample size

14 trials (15 arms): yogurt 9, fermented milk 4, kefir 2

Inclusion and exclusion criteria

Trials of fermented dairy

4. Methods and endpoints

Exposure / intervention

Yogurt, fermented milk, kefir

Comparator

Control

Endpoints

CRP, IFN-gamma, TNF-alpha, IL-6, IL-10, IL-2

Statistical methods

Random/fixed effects SMD

5. Actual results

Results

CRP SMD -0.21 (-0.40 to -0.02); IFN-gamma SMD +0.12 (0.01-0.23); no significant effect on TNF-alpha, IL-6, IL-10, IL-2. CRP decreased in participants with metabolic diseases.

Absolute risks

not reported

Authors' conclusion

Fermented dairy reduced CRP and increased IFN-gamma but had no effect on other markers; interpret with caution.

6. Strengths

  • Trial-based

7. Weaknesses

  • Small number of trials
  • Surrogate markers
  • SMD hard to interpret clinically

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Limited literature.

9. Assessment of the statistical interpretation

Small standardised effects.

10. Relevance to the specific claim

Fermented dairy, including yogurt that the system forbids, did not increase inflammatory markers and slightly lowered CRP.

11. Independent contrary findings

None found showing pro-inflammatory effects of yogurt in non-allergic people.

12. Transferability to Germany and Europe

Applicable.

13. Overall methodological judgement

Consistent with I-DRY-18/19.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilityunknown
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Clinical relevance.

15. Linked fact checks